311 related articles for article (PubMed ID: 37901450)
1. Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease.
Jagirdhar GSK; Perez JA; Perez AB; Surani S
World J Gastroenterol; 2023 Sep; 29(36):5211-5225. PubMed ID: 37901450
[TBL] [Abstract][Full Text] [Related]
2. Precision Medicine in Pediatric Inflammatory Bowel Disease.
Spencer EA; Dubinsky MC
Pediatr Clin North Am; 2021 Dec; 68(6):1171-1190. PubMed ID: 34736583
[TBL] [Abstract][Full Text] [Related]
3. Challenges in IBD Research: Precision Medicine.
Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
[TBL] [Abstract][Full Text] [Related]
4. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
Verstockt B; Noor NM; Marigorta UM; Pavlidis P; Deepak P; Ungaro RC;
J Crohns Colitis; 2021 Sep; 15(9):1431-1442. PubMed ID: 33730756
[TBL] [Abstract][Full Text] [Related]
5. Personalized medicine in inflammatory bowel disease: Perspectives on Asia.
Park SH; Park SH
J Gastroenterol Hepatol; 2022 Aug; 37(8):1434-1445. PubMed ID: 35726657
[TBL] [Abstract][Full Text] [Related]
6. Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.
Pinton P
Ann Med; 2023; 55(2):2300670. PubMed ID: 38163336
[TBL] [Abstract][Full Text] [Related]
7. Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology.
Liu XY; Tang H; Zhou QY; Zeng YL; Chen D; Xu H; Li Y; Tan B; Qian JM
World J Gastroenterol; 2023 Jan; 29(2):272-285. PubMed ID: 36687128
[TBL] [Abstract][Full Text] [Related]
8. Systems biology in inflammatory bowel diseases: ready for prime time.
Polytarchou C; Koukos G; Iliopoulos D
Curr Opin Gastroenterol; 2014 Jul; 30(4):339-46. PubMed ID: 24837229
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
10. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine.
Kumar M; Garand M; Al Khodor S
J Transl Med; 2019 Dec; 17(1):419. PubMed ID: 31836022
[TBL] [Abstract][Full Text] [Related]
11. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.
Fiocchi C; Dragoni G; Iliopoulos D; Katsanos K; Ramirez VH; Suzuki K;
J Crohns Colitis; 2021 Sep; 15(9):1410-1430. PubMed ID: 33733656
[TBL] [Abstract][Full Text] [Related]
12. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel Disease.
Torres J; Halfvarson J; Rodríguez-Lago I; Hedin CRH; Jess T; Dubinsky M; Croitoru K; Colombel JF
J Crohns Colitis; 2021 Sep; 15(9):1443-1454. PubMed ID: 33730755
[TBL] [Abstract][Full Text] [Related]
13. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions.
Gubatan J; Levitte S; Patel A; Balabanis T; Wei MT; Sinha SR
World J Gastroenterol; 2021 May; 27(17):1920-1935. PubMed ID: 34007130
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine in the treatment of inflammatory bowel diseases.
Parfenov AI; Knyazev OV; Kagramanova AV; Fadeeva NA
Ter Arkh; 2018 Feb; 90(2):4-11. PubMed ID: 30701765
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine in inflammatory bowel disease: concept, progress and challenges.
Borg-Bartolo SP; Boyapati RK; Satsangi J; Kalla R
F1000Res; 2020; 9():. PubMed ID: 32047622
[TBL] [Abstract][Full Text] [Related]
18. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease.
Peng L; Hu S; Yu Q; Chen Y
Inflamm Bowel Dis; 2022 Jun; 28(Suppl 2):S9-S15. PubMed ID: 34984463
[TBL] [Abstract][Full Text] [Related]
19. Big data in IBD: big progress for clinical practice.
Seyed Tabib NS; Madgwick M; Sudhakar P; Verstockt B; Korcsmaros T; Vermeire S
Gut; 2020 Aug; 69(8):1520-1532. PubMed ID: 32111636
[TBL] [Abstract][Full Text] [Related]
20. Clinical Value of Multiomics-Based Biomarker Signatures in Inflammatory Bowel Diseases: Challenges and Opportunities.
Bourgonje AR; van Goor H; Faber KN; Dijkstra G
Clin Transl Gastroenterol; 2023 Jul; 14(7):e00579. PubMed ID: 36881831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
